Literature DB >> 6861160

Kaposi's sarcoma: a new staging classification.

R L Krigel, L J Laubenstein, F M Muggia.   

Abstract

Reports of an unusual form of Kaposi's sarcoma in young homosexual men in North America have demonstrated that previous classification systems for this disease are incomplete. We describe the clinical characteristics of 49 homosexual men with Kaposi's sarcoma and propose a new staging for the disease. There appear to be four clinically distinct forms of Kaposi's sarcoma: stage I--the more typical locally indolent lesions occurring predominantly in elderly males in North America and Europe; stage II--a locally invasive and aggressive form seen almost exclusively in equatorial Africa; stage III--a disseminated mucocutaneous form, often with lymph node involvement, seen primarily in African children and North American male homosexuals; and stage IV--a disseminated, mucocutaneous form with visceral involvement also seen in African children and North American male homosexuals. These stages are further subtyped as to the presence or absence of the systemic signs of unexplained fever and/or weight loss. Further longitudinal follow-up of these recently diagnosed cases will hopefully document that this proposed staging system correlates with survival data and is useful in the evaluation of treatment regimens for uniformly defined patient groups.

Entities:  

Mesh:

Year:  1983        PMID: 6861160

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  10 in total

1.  Evaluation of different staging systems for Kaposi's sarcoma in HIV-infected patients.

Authors:  A Antinori; I Izzi; A Ammassari; G Camilli; R Murri; E Tamburrini
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.

Authors:  Kristine M Erlandson; Ivy Gudza; Suzanne Fiorillo; Buxton Ndemera; Robert T Schooley; Lovemore Gwanzura; Margaret Borok; Thomas B Campbell
Journal:  Int J Infect Dis       Date:  2014-04-21       Impact factor: 3.623

Review 3.  State of the art: gastrointestinal malignancies in the human immunodeficiency virus (HIV) population.

Authors:  Mary Koshy; John Kauh; Clifford Gunthel; Melissa Joyner; Jerome Landry; Charles R Thomas
Journal:  Int J Gastrointest Cancer       Date:  2005

4.  Phase II trial of ICRF-187 in patients with acquired immune deficiency related Kaposi's sarcoma (AIDS-KS).

Authors:  A Chachoua; M Green; J Wernz; F Muggia
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850

5.  AIDS-Kaposi Sarcoma and Classic Kaposi Sarcoma: are different ultrasound patterns related to different variants?

Authors:  Francesco M Solivetti; Fulvia Elia; Alessandra Latini; Carlo Cota; Paola Cordiali-Fei; Aldo Di Carlo
Journal:  J Exp Clin Cancer Res       Date:  2011-04-13

6.  Classic Kaposi's sarcoma in Morocco: clinico-epidemiological study at the National Institute of Oncology.

Authors:  Hassan Errihani; Narjisse Berrada; Soundouss Raissouni; Fadoi Rais; Hind Mrabti; Ghizlane Rais
Journal:  BMC Dermatol       Date:  2011-11-11

7.  Genotypic distribution of HHV-8 in AIDS individuals without and with Kaposi sarcoma: Is genotype B associated with better prognosis of AIDS-KS?

Authors:  Tania Regina Tozetto-Mendoza; Karim Yaqub Ibrahim; Adriana Fumie Tateno; Cristina Mendes de Oliveira; Laura Massami Sumita; Maria Carmem Arroyo Sanchez; Expedito José Luna; Ligia Camara Pierrotti; Jan Felix Drexler; Paulo Henrique Braz-Silva; Claudio Sérgio Pannuti; Camila Malta Romano
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 8.  Current and Future Tools for Diagnosis of Kaposi's Sarcoma.

Authors:  Nicolas Dupin; Aude Jary; Samia Boussouar; Charlotte Syrykh; Amir Gandjbakhche; Sébastien Bergeret; Romain Palich
Journal:  Cancers (Basel)       Date:  2021-11-25       Impact factor: 6.639

9.  Classical disseminated Kaposi's sarcoma in HIV-negative patients; an unusually indolent subtype.

Authors:  I G Ron; A Kuten; N Wigler; G Fried; S Nitezky; M J Inbar; J Dale; S Chaitchik
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

10.  Consensus of the Brazilian Society of Infectious Diseases and Brazilian Society of Clinical Oncology on the management and treatment of Kaposi's sarcoma.

Authors:  Érico Arruda; Alexandre Andrade dos Anjos Jacome; Ana Luiza de Castro Conde Toscano; Anderson Arantes Silvestrini; André Santa Bárbara Rêgo; Evanius Garcia Wiermann; Geraldo Felicio da Cunha; Heloisa Ramos Lacerda de Melo; Karen Mirna Loro Morejón; Luciano Zubaran Goldani; Luiz Carlos Pereira; Mariliza Henrique Silva; Mauro Sergio Treistman; Mônica Cristina Toledo Pereira; Patricia Maria Bezerra Xavier Romero; Rafael Aron Schmerling; Rodrigo Antonio Vieira Guedes; Veridiana Pires de Camargo
Journal:  Braz J Infect Dis       Date:  2014-02-11       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.